EXECUTIVE ENGAGEMENTS
POOL
453
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
91
Interactions with Platform & by Email
PARTICIPANTS
18
Unique # Participated
VALIDATIONS
7
Responses Validated*
COMPANIES
22
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
147
PAGES
199
EDITION
9
PRICE
USD 4950
CODE
MCP10955
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Cellular Health Testing estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at aCAGR of 8.5% over the period 2020-2027. Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
The Cellular Health Testing market in the U.S. is estimated at US$695.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$729.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
SELECT PLAYERS
Bio-Reference Laboratories, Inc.; Cell Science Systems Corp.; Cleveland Heartlab, Inc.; Dna Labs India; Genova Diagnostics; Immundiagnostik AG; Laboratory Corporation of America Holdings; Life Length; Quest Diagnostics, Inc.; Repeat Diagnostics Inc. (Repeat Dx); Segterra, Inc.; SpectraCell Laboratories, Inc.; Telomere Diagnostics, Inc. (Tdx); Zimetry LLC
SEGMENTS
» Collection Site (At-Home, In-Office, Other Sites) » Sample Type (Blood Samples, Other Samples) » Type (Single-Test Panels, Multi-Test Panels)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Cellular Health Testing – Revolutionary Technology Provides Overview of Health at Cellular Level |
| North America Projected to Retain Maximum Share in the Market |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Demand for Accurate Telomere Length Test Steers Market Growth |
| Digital Transformation in Healthcare to Offer Significant Market Gains |
| Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities |
| Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects |
| Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening |
| Exhibit: Percentage (In %) of Global Population Aged 65 and Above by Region |
| Exhibit: US Population (In Million) Aged 65 and Above for the Years 2018, 2021, 2024, 2027, and 2030 |
| Government Policies and Measures Promoting Preventative Healthcare Augurs Well |
| Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening |
| Exhibit: Global Precision Medicine Market (In US$ Billion) for the Years 2019, 2021, 2023, 2025 & 2027 |
| Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand |
| Key Challenges |
| Limited Reimbursement |
| Challenges in Sample Transportation |
| Variation in Pricing of Test Kits |
| Covid-19 Impact on Cellular Health Testing Market |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Samples Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Samples for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Sites for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 22 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com